CRL NYSE
Charles River Laboratories International, Inc.
1W: -0.9%
1M: -0.6%
3M: +25.4%
YTD: +43.3%
1Y: +70.2%
3Y: +48.8%
5Y: -36.7%
$290.19
+3.36 (+1.17%)
Weekly Expected Move ±4.9%
$261
$276
$290
$304
$319
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-03-29
Earliest Filing
2025-05-07
Latest Filing
investor: 3
target: 1
Counterparties (Filed by CRL)
4 relationshipsCompanies named in CRL's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Elliott Investment Management L.P. | — | investor | Entered into a Cooperation Agreement to appoint directors and gain board representation. | 2025-05-07 | View |
| Elliott Associates, L.P. | — | investor | Entered into a Cooperation Agreement to appoint directors and gain board representation. | 2025-05-07 | View |
| Elliott International, L.P. | — | investor | Entered into a Cooperation Agreement to appoint directors and gain board representation. | 2025-05-07 | View |
| Cognate BioServices, Inc. | — | target | Acquired by Charles River Laboratories International, Inc. for approximately $875 million in cash. | 2021-03-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-24 | Regulation FD; Exhibits | View | |
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-02-25 | Regulation FD Disclosure | View | |
| 2026-02-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-02-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2026-01-09 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-03 | Regulation FD Disclosure | View | |
| 2025-11-17 | Other Events | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-19 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-16 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-23 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-07 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-02-21 | Other Events | View | |
| 2025-02-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-14 | Regulation FD Disclosure | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR